These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3980330)

  • 21. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
    Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
    Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conclusion to be derived from in vitro data with respect to in vivo activity.
    Gotoh S
    Clin Ther; 1981; 4 Suppl A():8-17. PubMed ID: 7326694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver-loaded nanotubular structures enhanced bactericidal efficiency of antibiotics with synergistic effect in vitro and in vivo.
    Xu N; Cheng H; Xu J; Li F; Gao B; Li Z; Gao C; Huo K; Fu J; Xiong W
    Int J Nanomedicine; 2017; 12():731-743. PubMed ID: 28184157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antibacterial effects of low concentrations of antibiotics and host defence factors: a review.
    Ahlstedt S
    J Antimicrob Chemother; 1981 Nov; 8 Suppl C():59-70. PubMed ID: 7319989
    [No Abstract]   [Full Text] [Related]  

  • 25. Reasons for antimicrobial treatment failures and predictive value of in-vitro susceptibility testing in veterinary practice: An overview.
    Richter A; Feßler AT; Böttner A; Köper LM; Wallmann J; Schwarz S
    Vet Microbiol; 2020 Jun; 245():108694. PubMed ID: 32456814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo effects of rifampin on Staphylococcus epidermidis graft infections.
    Garrison JR; Henke PK; Smith KR; Brittian KR; Lam TM; Peyton JC; Bergamini TM
    ASAIO J; 1997; 43(1):8-12. PubMed ID: 9116358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of novel enolphosphate derivatives.
    Grison C; Barthes N; Finance C; Duval RE
    Bioorg Chem; 2010 Oct; 38(5):218-23. PubMed ID: 20655569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J; Jones RN; Bertino JS
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome.
    Spanu T; Santangelo R; Andreotti F; Cascio GL; Velardi G; Fadda G
    Int J Antimicrob Agents; 2004 Feb; 23(2):120-8. PubMed ID: 15013036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo animal models: quantitative models used for identifying antibacterial agents.
    Fernandez J
    Curr Protoc Pharmacol; 2006 Oct; Chapter 13():Unit13A.5. PubMed ID: 22294173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell level methods for studying the effect of antibiotics on bacteria during infection.
    Kogermann K; Putrinš M; Tenson T
    Eur J Pharm Sci; 2016 Dec; 95():2-16. PubMed ID: 27577009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antimicrobial activities of ribostamycin, gentamicin, ampicillin and lincomycin in vitro and in vivo.
    Inouye S; Watanabe T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):465-76. PubMed ID: 2632215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promises and failures of gallium as an antibacterial agent.
    Minandri F; Bonchi C; Frangipani E; Imperi F; Visca P
    Future Microbiol; 2014; 9(3):379-97. PubMed ID: 24762310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA; Petersen PJ; Weiss WJ; Jacobus NV; Testa RT; Tally FP
    J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract]   [Full Text] [Related]  

  • 35. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R; Berti M; Goldstein BP; Mapelli E; Randisi E; Scotti R; Arioli V
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the antibacterial activity in vitro of a combination of penicillin and other antibiotics on 127 strains isolated in an Oncological Institute].
    Buogo A; Zanuso G; Cattaneo P
    Minerva Med; 1975 Aug; 66(54):2690-6. PubMed ID: 1153119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reasons for discrepancies in laboratory and clinical data on the antibiotic sensitivity of gram-negative bacteria].
    Rozhavin MA
    Antibiot Khimioter; 1988 Jun; 33(6):460-3. PubMed ID: 3048219
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial activity of cefquinome against equine bacterial pathogens.
    Thomas E; Thomas V; Wilhelm C
    Vet Microbiol; 2006 Jun; 115(1-3):140-7. PubMed ID: 16455213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic sensitivity testing: correlations between in vitro tests in vivo situations.
    Devriese LA; Dutta GN
    Ann Rech Vet; 1981; 12(1):41-6. PubMed ID: 7044256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.